542 related articles for article (PubMed ID: 1926062)
1. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
Cattaneo M; Tenconi PM; Lecchi A; Mannucci PM
Thromb Res; 1991 Jun; 62(6):717-24. PubMed ID: 1926062
[TBL] [Abstract][Full Text] [Related]
2. "In vitro" and "ex vivo" effects of picotamide, a combined thromboxane A2-synthase inhibitor and -receptor antagonist, on human platelets.
Berrettini M; De Cunto M; Parise P; Grasselli S; Nenci GG
Eur J Clin Pharmacol; 1990; 39(5):495-500. PubMed ID: 1963845
[TBL] [Abstract][Full Text] [Related]
3. Effect of picotamide on the calcium mobilization and phospholipase C activation in human platelets.
Pulcinelli FM; Pignatelli P; Riondino S; Parisi S; Castiglioni C; Gazzaniga PP
Thromb Res; 1994 Jun; 74(5):453-61. PubMed ID: 8085246
[TBL] [Abstract][Full Text] [Related]
4. Characterization of N,N'-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets.
Gresele P; Deckmyn H; Arnout J; Nenci GG; Vermylen J
Thromb Haemost; 1989 Jun; 61(3):479-84. PubMed ID: 2552606
[TBL] [Abstract][Full Text] [Related]
5. Binding kinetics and antiplatelet activities of picotamide, a thromboxane A2 receptor antagonist.
Modesti PA; Cecioni I; Colella A; Costoli A; Paniccia R; Neri Serneri GG
Br J Pharmacol; 1994 May; 112(1):81-6. PubMed ID: 8032666
[TBL] [Abstract][Full Text] [Related]
6. Competitive inhibition of platelet thromboxane A2 receptor binding by picotamide.
Modesti PA; Colella A; Abbate R; Gensini G; Neri Serneri G
Eur J Pharmacol; 1989 Oct; 169(1):85-93. PubMed ID: 2532145
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by picotamide of thromboxane production in vitro and ex vivo.
Violi F; Ghiselli A; Iuliano L; Praticò D; Alessandri C; Balsano F
Eur J Clin Pharmacol; 1988; 33(6):599-602. PubMed ID: 3366163
[TBL] [Abstract][Full Text] [Related]
9. Modulation of platelet aggregation by areca nut and betel leaf ingredients: roles of reactive oxygen species and cyclooxygenase.
Jeng JH; Chen SY; Liao CH; Tung YY; Lin BR; Hahn LJ; Chang MC
Free Radic Biol Med; 2002 May; 32(9):860-71. PubMed ID: 11978487
[TBL] [Abstract][Full Text] [Related]
10. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
Patscheke H; Stegmeier K
Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
[TBL] [Abstract][Full Text] [Related]
11. Studies on in vitro effect of picotamide on human platelet aggregation in platelet-rich plasma and whole blood.
Anfossi G; Parisi S; Russo I; Mularoni EM; Massucco P; Cavalot F; Mattiello L; Trovati M
Thromb Res; 1995 Mar; 77(5):399-410. PubMed ID: 7778055
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of the persisting TxA2 receptor antagonism by picotamide.
Pulcinelli FM; Pignatelli P; Pesciotti M; Sebastiani S; Parisi S; Gazzaniga PP
Thromb Res; 1997 Feb; 85(3):207-15. PubMed ID: 9058495
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
Vezza R; Nenci GG; Gresele P
J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
[TBL] [Abstract][Full Text] [Related]
14. [In vitro study of the mechanism of the platelet anti-aggregant action of picotamide (G 137)].
Berrettini M; De Cunto M; Romanelli A; Volpato I; Orzalesi G; Nenci GG
Boll Soc Ital Biol Sper; 1983 Mar; 59(3):309-15. PubMed ID: 9704127
[No Abstract] [Full Text] [Related]
15. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
16. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
Gross PL; Rand ML; Barrow DV; Packham MA
Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effects of anti-thromboxane agents in platelet-vessel wall interaction.
Buccellati C; Ciceri P; Ballerio R; Casagrande C; Folco G; Nicosia S
Eur J Pharmacol; 2002 May; 443(1-3):133-41. PubMed ID: 12044803
[TBL] [Abstract][Full Text] [Related]
18. Interrelation of platelet aggregation, release reaction and thromboxane A2 production.
Balduini CL; Bertolino G; Noris P; Sinigaglia F; Bisio A; Torti M
Biochem Biophys Res Commun; 1988 Oct; 156(2):823-9. PubMed ID: 3190682
[TBL] [Abstract][Full Text] [Related]
19. Platelet aggregation in the Asian elephant is not dependent on thromboxane B2 production.
Gentry PA; Niemuller C; Ross ML; Liptrap RM
Comp Biochem Physiol A Comp Physiol; 1989; 94(1):47-51. PubMed ID: 2571453
[TBL] [Abstract][Full Text] [Related]
20. Antivasoconstrictor and antiaggregatory activities of picotamide unrelated to thromboxane A2 antagonism.
Vezza R; Spina D; Tallarida RJ; Nathan M; Page CP; Gresele P
Thromb Haemost; 1997 Nov; 78(5):1385-91. PubMed ID: 9408024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
